Giovanni Del Poeta
Giovanni Del Poeta
Professore Associato Malattie del Sangue, Universitą Tor Vergata, Roma, Italy
Verified email at uniroma2.it
TitleCited byYear
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
D Rossi, S Rasi, V Spina, A Bruscaggin, S Monti, C Ciardullo, ...
Blood 121 (8), 1403-1412, 2013
3792013
Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab
R Stasi, N Cooper, G Del Poeta, E Stipa, ML Evangelista, E Abruzzese, ...
Blood 112 (4), 1147-1150, 2008
3492008
Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML): Presented in part at the 42nd annual meeting of the American …
G Del Poeta, A Venditti, MI Del Principe, L Maurillo, F Buccisano, ...
Blood 101 (6), 2125-2131, 2003
3412003
Clinical significance of CD38 expression in chronic lymphocytic leukemia
G Del Poeta, L Maurillo, A Venditti, F Buccisano, AM Epiceno, G Capelli, ...
Blood 98 (9), 2633-2639, 2001
3362001
Response to B-cell–depleting therapy with rituximab reverts the abnormalities of T-cell subsets in patients with idiopathic thrombocytopenic purpura
R Stasi, G Del Poeta, E Stipa, ML Evangelista, MM Trawinska, N Cooper, ...
Blood 110 (8), 2924-2930, 2007
3012007
Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia: Presented in part at the 41st Annual Meeting of the American Society …
A Venditti, F Buccisano, G Del Poeta, L Maurillo, A Tamburini, C Cox, ...
Blood 96 (12), 3948-3952, 2000
2932000
Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab
R Stasi, E Stipa, G Del Poeta, S Amadori, AC Newland, D Provan
Rheumatology 45 (11), 1432-1436, 2006
2632006
Prognostic and therapeutic implications of minimal residual disease detection in acute myeloid leukemia
F Buccisano, L Maurillo, MI Del Principe, G Del Poeta, G Sconocchia, ...
Blood 119 (2), 332-341, 2012
2372012
Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia
V Gattei, P Bulian, MI Del Principe, A Zucchetto, L Maurillo, F Buccisano, ...
Blood 111 (2), 865-873, 2008
2372008
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia
MI Del Principe, G Del Poeta, F Buccisano, L Maurillo, A Venditti, ...
Blood 108 (3), 853-861, 2006
2092006
Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia
G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox, A Bruno, ...
Blood 87 (5), 1997-2004, 1996
1631996
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia
L Maurillo, F Buccisano, MI Del Principe, G Del Poeta, A Spagnoli, ...
48th Annual Meeting of the American-Society-of-Hematology 26 (30), 4944-4951, 2008
1392008
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
D Rossi, L Terzi-di-Bergamo, L De Paoli, M Cerri, G Ghilardi, A Chiarenza, ...
Blood 126 (16), 1921-1924, 2015
1352015
CD38/CD31, the CCL3 and CCL4 chemokines, and CD49d/vascular cell adhesion molecule-1 are interchained by sequential events sustaining chronic lymphocytic leukemia cell survival
A Zucchetto, D Benedetti, C Tripodo, R Bomben, M Dal Bo, D Marconi, ...
Cancer research 69 (9), 4001-4009, 2009
1322009
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study
R Bomben, M Dal Bo, D Capello, F Forconi, R Maffei, L Laurenti, D Rossi, ...
British journal of haematology 144 (4), 492-506, 2009
1172009
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia
F Buccisano, L Maurillo, V Gattei, G Del Poeta, MI Del Principe, MC Cox, ...
Leukemia 20 (10), 1783, 2006
1172006
Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia
A Venditti, G Del Poeta, F Buccisano, A Tamburini, MC Cox-Froncillo, ...
Leukemia 12 (7), 1056, 1998
1161998
Minimally differentiated acute myeloid leukemia (AML-M0): comparison of 25 cases with other French-American-British subtypes
A Venditti, G Del Poeta, F Buccisano, A Tamburini, MC Cox, R Stasi, ...
Blood 89 (2), 621-629, 1997
1111997
Cytogenetic and molecular diagnostic characterization combined to postconsolidation minimal residual disease assessment by flow cytometry improves risk stratification in adult …
F Buccisano, L Maurillo, A Spagnoli, MI Del Principe, D Fraboni, ...
Blood 116 (13), 2295-2303, 2010
1082010
CD49d Is the Strongest Flow Cytometry–Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
Pietro Bulian, Tait D. Shanafelt, Chris Fegan, Antonella Zucchetto, Lilla ...
JOURNAL OF CLINICAL ONCOLOGY 32 (9), 897-904, 2014
1052014
The system can't perform the operation now. Try again later.
Articles 1–20